TABLE 2.
Risk factors of disease severity in patients with COVID-191
| OR (95% CI) | P | |
|---|---|---|
| Sex | ||
| Female | Reference | |
| Male | 2.26 (1.06, 4.82) | 0.035 |
| Age groups | ||
| 13–42 y | Reference | |
| 43–55 y | 2.99 (0.99, 9.03) | 0.052 |
| 56–64 y | 1.88 (0.59, 5.94) | 0.29 |
| 65–92 y | 4.93 (1.44, 16.9) | 0.011 |
| Comorbidities | ||
| No | Reference | |
| Yes | 1.30 (0.58, 2.91) | 0.52 |
| BMI (continuous) | 0.95 (0.85, 1.06) | 0.33 |
| Smoking status | ||
| Never | Reference | |
| Former/current | 1.11 (0.44, 2.82) | 0.83 |
| Serum vitamin D status | ||
| Nondeficient2 | Reference | |
| Deficient3 | 2.72 (1.23,6.01) | 0.014 |
1
ORs, 95% CIs, and P values were adjusted by sex, age, comorbidities, BMI, smoking status, and vitamin D status; Reference = 1. COVID-19, coronavirus disease 2019; 25(OH)D, 25-hydroxyvitamin D.
2
Serum 25(OH)D concentrations ≥30 nmol/L.
3
Serum 25(OH)D concentrations <30 nmol/L.